CAXAX
Price
$19.68
Change
+$0.24 (+1.23%)
Updated
Aug 22 closing price
Net Assets
82.19M
PRAFX
Price
$16.15
Change
+$0.32 (+2.02%)
Updated
Aug 22 closing price
Net Assets
11B
Interact to see
Advertisement

CAXAX vs PRAFX

Header iconCAXAX vs PRAFX Comparison
Open Charts CAXAX vs PRAFXBanner chart's image
Catalyst/MAP Global Equity A
Price$19.68
Change+$0.24 (+1.23%)
VolumeN/A
Net Assets82.19M
T. Rowe Price Real Assets
Price$16.15
Change+$0.32 (+2.02%)
VolumeN/A
Net Assets11B
CAXAX vs PRAFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CAXAX vs. PRAFX commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAXAX is a StrongBuy and PRAFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRAFX has more cash in the bank: 11B vs. CAXAX (82.2M). CAXAX pays higher dividends than PRAFX: CAXAX (3.04) vs PRAFX (1.44). CAXAX was incepted earlier than PRAFX: CAXAX (14 years) vs PRAFX (15 years). CAXAX (1.60) is less costly to investors than PRAFX (0.90). PRAFX is a more actively managed with annual turnover of: 41.30 vs. CAXAX (22.00). CAXAX (2500) and PRAFX (2500) have matching initial minimum investment requirements. CAXAX annual gain was more profitable for investors over the last year : 8.48 vs. PRAFX (6.79). PRAFX (52.01) and CAXAX (49.52) have equivalent 5 years return.
CAXAXPRAFXCAXAX / PRAFX
Total Expense Ratio1.210.90134%
Annual Report Gross Expense Ratio1.600.90178%
Fund Existence14 years15 years-
Gain YTD15.50812.589123%
Front Load6%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets82.2M11B1%
Annual Yield % from dividends3.041.44212%
Returns for 1 year8.486.79125%
Returns for 3 years28.5519.27148%
Returns for 5 years49.5252.0195%
Returns for 10 years92.01101.3591%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABSCF1.26N/A
N/A
AB Science, Paris
INTI0.06N/A
N/A
Inhibitor Therapeutics Inc.
JNDOF22.75N/A
N/A
Jins Hldgs Inc.
CHBJF0.93N/A
N/A
China Citic Bank Corp., Ltd.
NXPRF158.17-3.56
-2.20%
Nexans Paris ACT